I G 225 (Gemfibrozil 600 mg)
Pill imprint I G 225 has been identified as Gemfibrozil 600 mg.
Gemfibrozil is used in the treatment of high cholesterol; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Gemfibrozil 600 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 600 mg
- 19.00 mm
- Elliptical / Oval
- Prescription only
silicon dioxide colloidal
methylcellulose (100 mPa.s)
|NDC Code||Manufacturer / Repackager|
|31722-0225||Camber Pharmaceuticals Inc.|
|68084-0473||Amerisource Health Services|
|24658-0130||Blu Pharmaceuticals LLC|
|67544-1111||Prepak Systems Inc (repackager)|
Note: Inactive ingredients may vary.
More about gemfibrozil
- Other brands: Lopid
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.